Enters into Letter of Intent with Innovate Biopharmaceuticals
Monster Digital, Inc. (NASDAQ: MSDI) ("Monster Digital"), today announced that it has entered into a non-binding letter of intent ("LOI") which contemplates a proposed reverse merger ("Merger") with Innovate Biopharmaceuticals, Inc. ("Innovate").
The LOI...
Simi Valley-based Pharmaceutic Litho and Label (“PLLC”) recently announced the acquisition of Plymouth Printing Company, Inc. (“Plymouth”). PLLC is a current Good Manufacturing Practices (cGMP) compliant specialty printer that exclusively serves the pharmaceutical, biotech and medical device industries.
Founded in...
